Management of skin metastases of ovarian cancer: a novel therapeutic approach
Strahlentherapie und Onkologie · 2026-09 · 202 (9) · 986-989
DOI: 10.1007/s00066-026-02546-9 ↗Kurz gefasst
Fallbericht in der Zeitschrift Strahlentherapie und Onkologie, online erschienen am 13.05.2026. Verfasst von Anne-Marie Lüchtenborg und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Robert-Koch-Strasse 3, 79106,…. Hauptthemen laut MEDLINE: Ovarian Neoplasms, Hyperthermia, Induced, Skin Neoplasms, Chemoradiotherapy. Die Arbeit nennt 16 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Dr. med. h.c. Erwin Braun Foundation, Universitätsklinikum Freiburg.
Abstract (Originalsprache)
Purpose
Ovarian cancer, one of the most lethal gynecological cancers, metastasizes into skin in 0.9%–5.8% of cases. Cutaneous metastases severely affect the quality of life of ovarian cancer patients. Although cutaneous metastases are rare, a therapeutic option for affected patients is needed. Herein, we present a combination therapy comprising radiation and mild hyperthermia with parallel chemotherapy as a treatment modality. Case A woman with extensive skin metastases of a high-grade, serous ovarian carcinoma on the thigh was treated with a combination of mild hyperthermia (39–43 °C) immediately followed by low-dose hypofractionated radiotherapy and parallel systemic treatment with carboplatin/gemcitabine. Mild hyperthermia, a strong radiosensitizer, was induced through water-filtered infrared A radiation (wIRA).
Results
The patient responded well and remained tumor free in the treatment area for more than 1 year.
Conclusion
Radiotherapy combined with mild hyperthermia in addition to systemic treatment allows for tumor control in the treated area, even with a reduced total radiation dose. To the best of our knowledge, this is the first report of a long-term tumor-free situation in the treatment area of skin metastases of ovarian cancer. This novel treatment might also be beneficial for skin metastases from other malignancies.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Robert-Koch-Strasse 3, 79106, Freiburg, Germany. anne-marie.luechtenborg@uniklinik-freiburg.de.
- Institute for Medical Biometry and Statistics, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
- Department of Dermatology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
- Department of Radiation Oncology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Robert-Koch-Strasse 3, 79106, Freiburg, Germany.
- Department of Obstetrics and Gynecology, Medical Center - University of Freiburg, Faculty of Medicine, University of Freiburg, Freiburg, Germany.
Förderung
- Dr. med. h.c. Erwin Braun Foundation
- Universitätsklinikum Freiburg
Zitieren
APA
Lüchtenborg, A. M., Sahlmann, J., Technau-Hafsi, K., Volegova-Neher, N., Rautenberg, B., Vaupel, P., Grosu, A. L., & Thomsen, A. R. (2026). Management of skin metastases of ovarian cancer: a novel therapeutic approach. Strahlentherapie und Onkologie, 202(9), 986-989. https://doi.org/10.1007/s00066-026-02546-9
Vancouver
Lüchtenborg AM, Sahlmann J, Technau-Hafsi K, Volegova-Neher N, Rautenberg B, Vaupel P, et al. Management of skin metastases of ovarian cancer: a novel therapeutic approach. Strahlentherapie und Onkologie. 2026;202(9):986-989. doi:10.1007/s00066-026-02546-9
BibTeX
@article{Lchtenborg2026,
author = {Lüchtenborg, Anne-Marie and Sahlmann, Jörg and Technau-Hafsi, Kristin and Volegova-Neher, Natalia and Rautenberg, Beate and Vaupel, Peter and Grosu, Anca-L and Thomsen, Andreas R},
title = {Management of skin metastases of ovarian cancer: a novel therapeutic approach},
journal = {Strahlentherapie und Onkologie},
year = {2026},
volume = {202},
number = {9},
pages = {986--989},
doi = {10.1007/s00066-026-02546-9}
}
EUVIMED